title: [Cost of the individual treatment of Trypanosoma brucei gambiense trypanosomiasis in a focus of infection in Niari (Congo)].
abstract: A survey carried out on 101 patients has shown that the treatment of human sleeping sickness, theoretically free, is relatively costly. The average total cost amount to 58,000 F C.F.A., ranging from free treatment up to much as 110,000 F C.F.A. This high cost in part explains the cases where treatment is refused, something which has frequently been observed in the Congo. It would therefore be desirable for patients, who are significant epidemiological reservoirs of T. b. gambiense, to receive economic aid.
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003223:Congo; D003365:Costs and Cost Analysis; D005260:Female; D006760:Hospitalization / Q000191:economics; D006801:Humans; D008297:Male; D014187:Transportation of Patients / Q000191:economics; D014347:Trypanosoma brucei gambiense; D014353:Trypanosomiasis, African / Q000191:economics* / Q000628:therapy
chemical_list: D000981:Antiprotozoal Agents
vernacular_title: Le coût du traitement individuel de la trypanosomiase à T.b. gambiense dans le foyer du Niari (Congo).